As rates fall, Australians have never been wealthier
Australians have never been wealthier, with new data revealing the value of our bank accounts, homes and shares rose to record highs in 2020 despite...
BUY | Medibank
Medibank is Australia’s largest private health insurer with ~35% market share. Operating in a heavily regulated industry, Australian health insurers...
BUY | Computershare Limited
Interest rate impacts aside, Computershare's underlying earnings have performed well in recent years, and we expect this to continue...
BUY | Macquarie Group Limited
Macquarie Group Limited (MQG) is Australia’s largest investment bank and a global leader in infrastructure development investment. Its diversified...
IMP Monthly Report | February 2021
February marked the twelve-month anniversary of the Australian share market hitting all time highs in 2020, just weeks before the severity of what was...
Chimeric Therapeutics Ltd: Research ahead of the rest
CAR-T is short for chimeric antigen receptor T-Cell. T-Cells have the capacity to hunt down and destroy abnormal cells, including some cancer cells...
9 common mistakes investors make
In the confusing and seemingly illogical world of investing, investors often make of a bunch of mistakes that keep them from reaching their goals...
Delta Drone International Limited (ASX:DLT)
Delta Drone International provides end-to-end commercial drone services in the mining, agriculture, and engineering sectors in six countries across...
Tour de Cure: Support a most worthwhile cause
Tour de Cure raises vital funds to support the researchers, surgeons, and clinicians who dedicate their lives to finding a cure for cancer...
BUY | Woodside Petroleum Limited
Woodside leveraged their existing infrastructure for low-risk opportunities, with investments ready in multiple projects to ensure the next phase of growth.
BUY | Suncorp Group Limited
Suncorp is one of the largest general insurers in Australia and New Zealand, with its smaller banking division contributing around 1/3 of group profit...
In-depth: Paradigm Biopharmaceuticals Ltd
Paradigm begins 2021 on the cusp of several pivotal Phase 3 clinical trials, with aspirations to successfully commercialise pentosan polysulfate sodium (PPS
IMP Monthly Report | January 2021
Despite a significant pull-back at the end of the month, the Australian share market (as measured by the S&P/ASX 200 Index) managed to post a 0.31% gain...
Motio Limited (ASX:MXO)
MXO has been transformed, with a clear strategy to optimise and take advantage of a rapidly evolving industry in the midst of consolidation...
Earnings season is about to start – here’s what to expect
“Don’t extrapolate from peaks or troughs”. That’s the short but sharp advice of Morningstar Head of Equity Research, Peter Warnes...
IMP Monthly Report | December 2020
December probably typified what a historically dichotomous year we experienced in 2020...
4 reasons not to hold too much cash
While cash is comforting in a crisis, if you’re fortunate enough to have saved money, here are four reasons not to leave this lingering in cash...
BUY | Family Zone Cyber Security Limited
Developing & distributing cyber safety products & services in Australia, the United States & New Zealand, we see FZO as being the right Software as a...